Search
for
Sort by
Research 271–300 of 1000+
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
- Androgen Excess in Women: Experience with Over 1000 Consecutive Patients
- Androgens and Cardiovascular Disease
- Different Levels of 5α-Reductase Type I and II, Aromatase, and Androgen Receptor in Hair Follicles of Women and Men with Androgenetic Alopecia
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society
- Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred because of Clinical Hyperandrogenism
- Molecular basis of androgen insensitivity
- Polymorphism of the Androgen Receptor Gene is Associated with Male Pattern Baldness
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- Fetal Programming of Polycystic Ovary Syndrome by Androgen Excess: Evidence from Experimental, Clinical, and Genetic Association Studies
- Androgen Therapy in Women: A Reappraisal: An Endocrine Society Clinical Practice Guideline
- Differences in Hair Follicle Dermal Papilla Volume are Due to Extracellular Matrix Volume and Cell Number: Implications for the Control of Hair Follicle Size and Androgen Responses
- Side effects of androgen deprivation therapy: monitoring and minimizing toxicity
- Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp
- Intermolecular NH2-/Carboxyl-terminal Interactions in Androgen Receptor Dimerization Revealed by Mutations That Cause Androgen Insensitivity
- ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
- A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia
- Androgens and hair growth
- Discovery of Nonsteroidal Androgens
- Androgen receptor–mediated inhibition of cutaneous wound healing
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Sebocytes are the Key Regulators of Androgen Homeostasis in Human Skin
- Genetic Variation in the Human Androgen Receptor Gene Is the Major Determinant of Common Early-Onset Androgenetic Alopecia
- Androgen‐inducible TGF‐β1 from balding dermal papilla cells inhibits epithelial cell growth: a clue to understanding paradoxical effects of androgen on human hair growth
- Androgen Receptor Polymorphisms (CAG Repeat Lengths) in Androgenetic Alopecia, Hirsutism, and Acne
- Androgens Protect against Apolipoprotein E4-Induced Cognitive Deficits
- 3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.
- Clinical and Biochemical Parameters of Androgen Action in Normal Healthy Caucasian<i>Versus</i>Chinese Subjects